Administration of blocking anti-ICOSL mAbs results in a striking reduction in the development of experimental rheumatoid arthritis and lupus nephritis, which correlates with reduced T follicular helper (Tfh) differentiation and germinal center formation [29]. This evidence concerns the gene ICOSLG and lupus nephritis.